Chief Business Officer Ahmed Mousa resigns to become CEO of Vicore Pharma

PALVELLA THERAPEUTICS, INC.

Ahmed Mousa to resign as SVP, Chief Business Officer, General Counsel & Corporate Secretary effective September 11, 2023.
Resignation to become CEO of Vicore Pharma Holding AB; no disagreement with Pieris on any matter.
CEO Stephen Yoder will oversee corporate and business development following Mousa's departure.
Mousa expected to serve as strategic advisor for a transition period subject to mutual terms.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ahmed Mousa

Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary

PVLA · PALVELLA THERAPEUTICS, INC.

Effective: 2023-09-11
Filed: July 13, 2023, 7:59 PM ET

On July 13, 2023, Ahmed Mousa, the Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary of Pieris Pharmaceuticals, Inc. (the “Company”), gave notice that he will resign from the Company effective September 11, 2023 in order to become chief executive officer of Vicore Pharma Holding AB.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ahmed Mousa resigned as Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary at PALVELLA THERAPEUTICS, INC..

Action: resigned
Role: Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary

Exact text from the filing

On July 13, 2023, Ahmed Mousa, the Senior Vice President, Chief Business Officer, General Counsel & Corporate Secretary of Pieris Pharmaceuticals, Inc. (the “Company”), gave notice that he will resign from the Company effective September 11, 2023 in order to become chief executive officer of Vicore Pharma Holding AB.

View on SEC.gov

PALVELLA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-019831

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.